Search

Learn how CAR T cell therapy and the expertise of MSK gave Guillaume Arnould another option for treating multiple myeloma, after other therapies failed.

… Tuesday, November 7, 2023 Shortly after finding out his wife was pregnant with their son, Guillaume Arnould got terrible news about his own health: He had multiple myeloma , a rare blood cancer. He was just 33 years old. The following six years were a grueling succession of stem cell transplants stem

Meet Matthew Solowsky, a Navy veteran and Senior Research Technician in the Center for Molecular Oncology at Memorial Sloan Kettering Cancer Center.

… Thursday, November 11, 2021 Matthew Solowsky says he has always been driven and focused. “The hardships from my childhood made me want to rise above circumstances that were outside of myself,” says Mr. Solowsky, who is now a Senior Research Technician in the Center for Molecular Oncology (CMO)  at Memorial

Bispecific antibodies bind to two antigens or two parts of the same antigen at the same time. The U.S. Food and Drug Administration (FDA) recently approved two CD20xCD3 bispecific antibodies —mosunetuzumab (mosun) for patients with relapsed or refractory follicular lymphoma and glofitamab (glofit) for patients with relapsed or refractory diffuse B cell lymphoma (DLBCL) or large B cell lymphoma (LBCL) treated with two or more prior lines of therapy.

… Monday, December 11, 2023 Bispecific antibodies bind to two antigens or two parts of the same antigen at the same time. The U.S. Food and Drug Administration (FDA) recently approved two CD20xCD3 bispecific antibodies —mosunetuzumab (mosun) for patients with relapsed or refractory follicular lymphoma

Meet author Amy Blumenfeld, whose experience as a pediatric patient at Memorial Sloan Kettering inspired her first novel, The Cast.

… Friday, November 16, 2018 Summary In 1989, 15-year-old Amy Blumenfeld was treated for Hodgkin lymphoma at Memorial Sloan Kettering. Her first novel, The Cast, is loosely based on her experience. In the late 1980s, when she was 13, Amy Blumenfeld was diagnosed with Hodgkin lymphoma. She had 11 months

New MSK research provides insights into how BRCA2 promotes genomic integrity; illuminates how embryonic cells can develop without key amino acids; explores how the microbiome bounces back after antibiotic treatment; and investigates acquired resistance to immunotherapy in non-small cell lung cancer.

… Monday, January 29, 2024 New research from Memorial Sloan Kettering Cancer Center (MSK) provides insights into how BRCA2 promotes genomic integrity; illuminates how embryonic cells can develop without key amino acids; explores how the microbiome bounces back after antibiotic treatment; and investigates

Olympic gymnast Shannon Miller was diagnosed with germ cell ovarian cancer, a very rare disease, in 2011 and treated at Memorial Sloan Kettering. Learn more about her inspiring story.

… Thursday, July 3, 2014 Summary Olympic gymnast Shannon Miller was diagnosed with germ cell ovarian cancer, a very rare disease, in 2011 and treated at Memorial Sloan Kettering. Learn more about her inspiring story. “Celebrating survivorship is an important reminder of why MSK exists.” —Memorial Sloan

Multiple copies of a gene called YES1 appear to be responsible for certain precision drugs losing their effectiveness.

… Thursday, June 7, 2018 Summary A collaborative study between scientists at Memorial Sloan Kettering and the New York Genome Center has identified one way that lung cancer cells outsmart a common targeted drug therapy. The results, reported in the Proceedings of the National Academy of Sciences, pave

Radiologist and molecular imaging researcher Moritz Kircher was awarded a Brain and Immuno-Imaging Grant by The Dana Foundation. This three-year grant supports the development of a dual-modality MRI-Raman nanoparticle that allows combined pre-and intra-operative visualization of glioblastomas.

… Wednesday, November 30, 2011 Radiologist and molecular imaging researcher Moritz Kircher  was awarded a Brain and Immuno-Imaging Grant by The Dana Foundation. This three-year grant supports the development of a dual-modality MRI-Raman nanoparticle that allows combined pre-and intra-operative visualization

A new drug is showing very encouraging results against pancreatic cancer, thanks to clinical trials of daraxonrasib at MSK and other hospitals.

… Thursday, May 7, 2026 A drug that may offer new hope for people facing pancreatic cancer has been authorized by the U.S. Food & Drug Administration (FDA) for expanded access, meaning more patients can take the drug while it is being studied.  Pancreatic cancer is one of the most aggressive types of cancer

Read how prostate cancer screening saved a man's life and inspired his activism for cancer awareness in the Black community.

… Friday, May 8, 2026   It started with a simple blood test. Eddie Baynes, a finance executive at Verizon and a proud Morehouse College graduate, joined a prostate cancer awareness drive with his fraternity brothers of Alpha Phi Alpha Fraternity, Inc. One of them, Derrick Butts, had survived the disease